Contents

Current Pharmaceutical Design, Volume 14 - Number 5

Editorial [ Advances in Heme Oxygenase Research as a Potential Therapeutic Strategy Executive Editor: M.J. Alcaraz]

, 14(5): 411

M. J. Alcaraz


DOI: 10.2174/138161208783597344




Heme Oxygenase: A Target Gene for Anti-Diabetic and Obesity

, 14(5): 412 - 421

N. G. Abraham, P. L. Tsenovoy, J. McClung and G. S. Drummond


DOI: 10.2174/138161208783597371




Role of Heme Oxygenase-1 in Vascular Disease

, 14(5): 422 - 428

Hun-Taeg Chung, Hyun-Ock Pae and Young-Nam Cha


DOI: 10.2174/138161208783597335




Heme Oxygenase-1 as a Therapeutic Target in Neurodegenerative Diseases and Brain Infections

, 14(5): 429 - 442

Antonio Cuadrado and Ana I. Rojo


DOI: 10.2174/138161208783597407




Cerebroprotective Functions of HO-2

, 14(5): 443 - 453

Helena Parfenova and Charles W. Leffler


DOI: 10.2174/138161208783597380




The Role of Heme Oxygenase-1 in T Cell-Mediated Immunity: The All Encompassing Enzyme

, 14(5): 454 - 464

Z. W. Xia, W. W. Zhong, J. S. Meyrowitz and Z. L. Zhang


DOI: 10.2174/138161208783597326




Carbon Monoxide-Releasing Molecules: A Pharmacological Expedient to Counteract Inflammation

, 14(5): 465 - 472

Maria Jose Alcaraz, Maria Isabel Guillen, Maria Luisa Ferrandiz, Javier Megias and Roberto Motterlini


DOI: 10.2174/138161208783597362




Inducers of Heme Oxygenase-1

, 14(5): 473 - 486

M. L. Ferrandiz and I. Devesa


DOI: 10.2174/138161208783597399




Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication

, 14(5): 487 - 495

Sho-ichi Yamagishi, Kazuo Nakamura, Takanori Matsui, Yoshihiro Noda and Tsutomu Imaizumi


DOI: 10.2174/138161208783597416




The Protective Role of Steroids in Ischemia-Reperfusion Injury of the Liver

, 14(5): 496 - 503

Carlo Pulitano and Luca Aldrighetti


DOI: 10.2174/138161208783597353




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science